Specifically, p53 mediates PRMT1 protein downregulation, leading to inhibition of the Warburg effect and, in turn, suppression of NSCLC cell proliferation under conditions of glucose insufficiency. This evidence concerns the gene TP53 and non-small cell lung carcinoma.